Coexisting nocturia and insomnia in older adults: Planning a trial of integrated therapy
老年人共存夜尿和失眠:计划综合治疗试验
基本信息
- 批准号:10205964
- 负责人:
- 金额:$ 10.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBedsBehavior TherapyBehavioralChronic InsomniaClinical Practice GuidelineClinical TrialsCognitiveCognitive TherapyData CollectionEducationElderlyEnrollmentExerciseFoundationsFrequenciesFutureHabitsHealthHealth Services ResearchIndividualInterventionIntervention TrialLife StyleManualsMeasuresMethodsMulti-Institutional Clinical TrialNocturiaNurse PractitionersOutcomeParticipantPelvic Floor MusclePersonal SatisfactionPharmacological TreatmentPharmacotherapyPilot ProjectsPopulationPositioning AttributeProceduresProtocols documentationProviderRandomizedRandomized Controlled TrialsRelaxationResearchResearch PersonnelRiskRisk FactorsSeveritiesSiteSleepSleep DisordersSleep disturbancesSleeplessnessStandardizationSymptomsSyndromeTarget PopulationsTechniquesTestingTherapeuticTimeTrainingTreatment ProtocolsVisitWakefulnessbasecomparative effectiveness trialconditioningcopingeffectiveness evaluationefficacy evaluationgroup interventionimprovedmulti-site trialnovelolder menolder womenprogramsrecruitsleep healthsleep qualitysuccesssynergismurinary
项目摘要
Nocturia occurs in nearly 50% of older adults and chronic insomnia disorder occurs in up to one-third of
older adults. These two conditions frequently coexist in the same individual and contribute to sleep
disturbance. As a geriatric syndrome, the causes of sleep disturbance are multifactorial and some risk factors
and health conditions act synergistically to increase the risk within a single individual. Yet treatments for either
nocturia or insomnia typically focus on an individual condition (e.g., nocturia) without addressing the other
condition (e.g., insomnia). Given the synergism of these two conditions, an integrated treatment that addresses
both nocturia and insomnia simultaneously has the potential to yield significant improvements in each condition
and overall sleep.
Recent evidence supports a future trial of integrated treatment for nocturia and insomnia disorder,
particularly one that employs non-pharmacologic, non-surgical strategies. Studies find that behavioral
treatment for nocturia improves insomnia symptoms and sleep quality. Similarly, behavioral treatments for
insomnia reduce nocturia frequency and bother. In our recently piloted multicomponent behavioral intervention,
which incorporated both sleep-related (i.e., sleep hygiene) and nocturia (e.g., pelvic floor muscle exercise-
based urge suppression at night) treatments, the intervention reduced nocturia frequency equal to or better
than drug therapy. The proposed integrated treatment addresses the bidirectional relationship between
nocturia and insomnia. Wakefulness at night increases the opportunity for individuals to sense the urge to void.
Nocturia also contributes to awakenings, difficulty returning to sleep, and excessive time in bed, which worsens
insomnia and increases the opportunity to sense the urge to void. Our pilot study results suggest that a full-
scale, comparative-effectiveness trial is needed to test this promising treatment.
The objective of this R34 application is to plan for a future multi-site clinical trial that will test a novel,
integrated non-pharmacologic (behavioral, cognitive, and lifestyle) treatment for coexisting nocturia and
insomnia in an older adult population. The core components of this 5-week treatment (delivered by advanced
practice providers such as nurse practitioners) will include education about the two conditions and their
interactions, behavioral conditioning exercises for both conditions, relaxation exercises for both
conditions, sleep restriction (a core component of cognitive behavioral therapy for insomnia), pelvic floor
muscle training, lifestyle habits management, cognitive restructuring, and coping techniques. A full-scale,
multisite trial is needed to determine the efficacy of the integrated program in improving sleep and nocturia
outcomes with adequate power and with generalizability across multiple sites. In this application we propose
the planning activities (developing, refining, and testing) of the protocol and procedures for a future full-scale
trial conducted at multiple sites. The research team, which includes established investigators with expertise in
urinary symptoms, sleep disorders, clinical trials, and health services research, has been collaborating to
advance the field of nocturia-insomnia research.
近 50% 的老年人患有夜尿症,多达三分之一的老年人患有慢性失眠症
老年人。这两种情况经常同时存在于同一个人身上并影响睡眠
干扰。作为一种老年综合症,睡眠障碍的原因是多因素的,其中一些危险因素
和健康状况协同作用,增加单个个体的风险。然而治疗方法
夜尿症或失眠症通常只关注某一种情况(例如夜尿症),而不关注其他情况
状况(例如失眠)。鉴于这两种情况的协同作用,需要采取综合治疗来解决
夜尿症和失眠症同时存在,有可能显着改善每种情况
和整体睡眠。
最近的证据支持未来对夜尿症和失眠症进行综合治疗的试验,
特别是采用非药物、非手术策略的一种。研究发现,行为
夜尿症治疗可改善失眠症状和睡眠质量。同样,行为治疗
失眠减少夜尿频率和烦恼。在我们最近试点的多成分行为干预中,
其中包括与睡眠相关的(即睡眠卫生)和夜尿(例如盆底肌肉锻炼)
基于夜间冲动抑制)治疗,干预措施将夜尿频率降低等于或更好
比药物治疗。所提出的综合治疗解决了之间的双向关系
夜尿和失眠。夜间清醒会增加人们感受到排尿冲动的机会。
夜尿还会导致觉醒、入睡困难以及卧床时间过长,从而导致病情恶化
失眠并增加感觉到排尿冲动的机会。我们的试点研究结果表明,全面
需要进行大规模的比较有效性试验来测试这种有希望的治疗方法。
该 R34 申请的目标是规划未来的多中心临床试验,该试验将测试一种新颖的、
针对共存的夜尿症和夜尿症的综合非药物(行为、认知和生活方式)治疗
老年人群的失眠。这个为期 5 周的治疗的核心组成部分(由先进的
实践提供者(例如执业护士)将包括有关这两种情况及其影响的教育
互动、针对两种情况的行为调节练习、针对两种情况的放松练习
状况、睡眠限制(失眠认知行为疗法的核心组成部分)、盆底
肌肉训练、生活习惯管理、认知重建和应对技巧。一个全面的、
需要进行多中心试验来确定综合方案在改善睡眠和夜尿方面的功效
结果具有足够的力量和跨多个站点的普遍性。在此应用中,我们建议
未来全面的协议和程序的规划活动(开发、完善和测试)
在多个地点进行了试验。研究团队包括具有以下专业知识的资深研究人员
泌尿系统症状、睡眠障碍、临床试验和健康服务研究,一直在合作
推进夜尿失眠研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Constance Fung其他文献
Constance Fung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Constance Fung', 18)}}的其他基金
A multi-center trial to improve nocturia and sleep in older adults
一项改善老年人夜尿和睡眠的多中心试验
- 批准号:
10718768 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
The Efficacy of Masked Tapering on Discontinuation of Hypnotics in Older Veterans
蒙面减量对老年退伍军人停止催眠药的疗效
- 批准号:
10290894 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
A novel mechanism for helping older adults discontinue use of sleeping pills
帮助老年人停止使用安眠药的新机制
- 批准号:
10160732 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
The Efficacy of Masked Tapering on Discontinuation of Hypnotics in Older Veterans
蒙面减量对老年退伍军人停止催眠药的疗效
- 批准号:
9495636 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
A novel mechanism for helping older adults discontinue use of sleeping pills
帮助老年人停止使用安眠药的新机制
- 批准号:
9927969 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
The Efficacy of Masked Tapering on Discontinuation of Hypnotics in Older Veterans
蒙面减量对老年退伍军人停止催眠药的疗效
- 批准号:
10197053 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
A novel mechanism for helping older adults discontinue use of sleeping pills
帮助老年人停止使用安眠药的新机制
- 批准号:
10406305 - 财政年份:2018
- 资助金额:
$ 10.99万 - 项目类别:
Improving Older Adults' Decision Making For Obstructive Sleep Apnea Treatment
改善老年人阻塞性睡眠呼吸暂停治疗的决策
- 批准号:
8591037 - 财政年份:2013
- 资助金额:
$ 10.99万 - 项目类别:
Improving Older Adults' Decision Making For Obstructive Sleep Apnea Treatment
改善老年人阻塞性睡眠呼吸暂停治疗的决策
- 批准号:
8856457 - 财政年份:2013
- 资助金额:
$ 10.99万 - 项目类别:
Improving Older Adults' Decision Making For Obstructive Sleep Apnea Treatment
改善老年人阻塞性睡眠呼吸暂停治疗的决策
- 批准号:
9058968 - 财政年份:2013
- 资助金额:
$ 10.99万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
A multi-center trial to improve nocturia and sleep in older adults
一项改善老年人夜尿和睡眠的多中心试验
- 批准号:
10718768 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
Determining the effect of early resource scarcity on adolescent addiction-related behavior and cell-type specific transcription
确定早期资源稀缺对青少年成瘾相关行为和细胞类型特异性转录的影响
- 批准号:
10825012 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
The Effects of the COVID-19 Pandemic on Long-Term Care for High-Need Older Adults with and without Alzheimer’s Disease and Related Dementias
COVID-19 大流行对患有或不患有阿尔茨海默病和相关痴呆症的高需求老年人的长期护理的影响
- 批准号:
10589386 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别:
Training of machine learning algorithms for the classification of accelerometer-measured bednet use and related behaviors associated with malaria risk
训练机器学习算法,用于对加速计测量的蚊帐使用和与疟疾风险相关的相关行为进行分类
- 批准号:
10727374 - 财政年份:2023
- 资助金额:
$ 10.99万 - 项目类别: